Antiviral therapy for pre- and post-liver transplantation patients with hepatitis B.
Tan
Jessica
J
Lok
Anna S F
AS
D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D004279:DNA, Viral / Q000097:blood; D024882:Drug Resistance, Viral; D004359:Drug Therapy, Combination; D006147:Guanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006509:Hepatitis B / Q000097:blood / Q000188:drug therapy* / Q000517:prevention & control*; D006515:Hepatitis B virus / Q000235:genetics; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D019259:Lamivudine / Q000009:adverse effects / Q000627:therapeutic use; D016031:Liver Transplantation / Q000009:adverse effects* / Q000379:methods; D063065:Organophosphonates / Q000009:adverse effects / Q000627:therapeutic use; D055502:Secondary Prevention; D000068698:Tenofovir
D000998:Antiviral Agents; D004279:DNA, Viral; D063065:Organophosphonates; D019259:Lamivudine; C413685:entecavir; D006147:Guanine; D000068698:Tenofovir; D000225:Adenine; C106812:adefovir dipivoxil